SOLIGENIX, INC. — Director's Dealing 2018

Dec 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2018-12-13

Reporting Person: Krumeich Karen R (SVP and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-13	Option (Right to Buy)	$0.97	A	40000	Acquired	2028-12-12	Common Stock (40000)	Direct

Footnotes

F1: The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 13, 2018.